|
|
COVID-19 drug practices risk antimicrobial resistance evolution
Ebrahim Afshinnekoo
,
Chandrima Bhattacharya
,
Ana Burguete-García
,
Eduardo Castro-Nallar
,
Youping Deng
,
et al.
Journal articles
hal-03160391v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Target Engagement and Binding Mode of an Antituberculosis Drug to Its Bacterial Target Deciphered in Whole Living Cells by NMR
Guillaume Bouvier
,
Catherine Simenel
,
Jichan Jang
,
Nitin Kalia
,
Inhee Choi
,
et al.
Journal articles
hal-02326246v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting.
Marie Morille
,
Tristan Montier
,
Pierre Legras
,
Nathalie Carmoy
,
Priscille Brodin
,
et al.
Journal articles
inserm-00491402v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Antileishmanial high-throughput drug screening reveals drug candidates with new scaffolds.
Jair L Siqueira-Neto
,
Ok-Ryul Song
,
Hyunrim Oh
,
Jeong-Hun Sohn
,
Gyongseon Yang
,
et al.
Journal articles
pasteur-00696809v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Mycobacterium tuberculosis Controls Phagosomal Acidification by Targeting CISH-Mediated Signaling
Christophe J Queval
,
Ok-Ryul Song
,
Jean-Philippe Carralot
,
Jean-Michel Saliou
,
Antonino Bongiovanni
,
et al.
Journal articles
pasteur-02046436v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Molecular basis of the interaction of the human tyrosine phosphatase PTPN3 with the hepatitis B virus core protein
Mariano Genera
,
Barbara Quioc-Salomon
,
Antonin Nourisson
,
Baptiste Colcombet-Cazenave
,
Ahmed Haouz
,
et al.
Journal articles
hal-03157335v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Contactin 4, -5 and -6 differentially regulate neuritogenesis while they display identical PTPRG binding sites.
Oriane Mercati
,
Anne Danckaert
,
Gwenaëlle André-Leroux
,
Marco Bellinzoni
,
Laura Gouder
,
et al.
Journal articles
pasteur-01517024v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|